Timing of Earliest Documented Positive Hepatitis C Laboratory Result Relative to Delivery Among Pregnant Persons With Active Infection in West Virginia, 2022–2023
Journal of Viral Hepatitis · 2026
DOI: 10.1111/jvh.70247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2026. Verfasst von Kady Pack und 7 weiteren Autor:innen. Beteiligte Einrichtung: Bureau for Public Health, West Virginia Department of Health, Charleston, West Virginia, USA. Hauptthemen laut MEDLINE: Pregnancy Complications, Infectious, Hepatitis C, Infectious Disease Transmission, Vertical. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: JG CDC HHS, Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Direct‐acting antiviral therapy can cure hepatitis C virus (HCV) infection; however, because treatment is not recommended during pregnancy, preconception treatment remains the primary strategy to prevent perinatal HCV exposure. West Virginia birth records from 2022 to 2023 were linked with statewide HCV laboratory surveillance data. This linked dataset was used to identify births to persons with active HCV infection and characterize the timing of the earliest documented positive HCV laboratory result relative to delivery. A total of 426 deliveries resulting in 433 HCV‐exposed live‐born infants were identified. Most pregnant persons were aged 25–34 years, White and insured by Medicaid. Overall, 38.5% had their earliest documented positive HCV laboratory result more than 5 years prior to delivery, 36.9% had their first documented positive test 1–5 years prior to delivery and 24.6% had their first documented positive test within 1 year before delivery and up to 2 weeks postpartum. These findings indicate that many pregnant persons with active HCV infection had documented longstanding infection prior to pregnancy, highlighting opportunities to strengthen linkage to care and access to curative treatment before pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bureau for Public Health, West Virginia Department of Health, Charleston, West Virginia, USA.
- Department of Cancer Prevention and Control, West Virginia University School of Medicine, Morgantown, West Virginia, USA.
- WVU Cancer Institute, Morgantown, West Virginia, USA.
- Office of Management Information Services, West Virginia Departments of Health, Health Facilities, and Human Services, Charleston, West Virginia, USA.
ORCID-Profile: Birgit Shanholtzer, Alana G Hudson
Förderung
- JG CDC HHS
- Centers for Disease Control and Prevention
Zitieren
APA
Pack, K., Yousaf, M., Wattick, R. A., Armstrong, B., Shanholtzer, B., Chaney, T., McBee, S., & Hudson, A. G. (2026). Timing of Earliest Documented Positive Hepatitis C Laboratory Result Relative to Delivery Among Pregnant Persons With Active Infection in West Virginia, 2022–2023. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.70247
Vancouver
Pack K, Yousaf M, Wattick RA, Armstrong B, Shanholtzer B, Chaney T, et al. Timing of Earliest Documented Positive Hepatitis C Laboratory Result Relative to Delivery Among Pregnant Persons With Active Infection in West Virginia, 2022–2023. Journal of Viral Hepatitis. 2026. doi:10.1111/jvh.70247
BibTeX
@article{Pack2026,
author = {Pack, Kady and Yousaf, Mamoon and Wattick, Rachel A and Armstrong, Brett and Shanholtzer, Birgit and Chaney, Tonya and McBee, Shannon and Hudson, Alana G},
title = {Timing of Earliest Documented Positive Hepatitis C Laboratory Result Relative to Delivery Among Pregnant Persons With Active Infection in West Virginia, 2022–2023},
journal = {Journal of Viral Hepatitis},
year = {2026},
doi = {10.1111/jvh.70247}
}
EUVIMED